![Yvonne Perlberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yvonne Perlberg
Directeur/Membre du Conseil chez EnGeneIC Pty Ltd.
Profil
Yvonne Perlberg is currently a Director at EnGeneIC Pty Ltd.
She graduated from Central Michigan University with a graduate degree and from Indiana University with an undergraduate degree.
Postes actifs de Yvonne Perlberg
Sociétés | Poste | Début |
---|---|---|
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Directeur/Membre du Conseil | 25/01/2016 |
Formation de Yvonne Perlberg
Indiana University | Undergraduate Degree |
Central Michigan University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
EnGeneIC Pty Ltd.
![]() EnGeneIC Pty Ltd. BiotechnologyHealth Technology EnGeneIC Pty Ltd. develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer. It offers targeted drug delivery, gene silencing, canine cancers and principal characteristics technology solutions. The company was founded by Jennifer A. MacDiarmid and Himanshu Brahmbhatt in 2001 and is headquartered in Sydney, Australia. | Health Technology |